U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 6060700

Microwave Oven With Removable Storage Cassette in Dashboard of Motor Vehicle

A microwave oven adapted for use within a motor vehicle dashboard area. The microwave oven has a removable storage cassette, and slidable platforms for securing and serving containers of beverages and foods.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Attorney: Grant D. Green;Patent Law Department, M/S A2-250


Number of applications: 17
Last date: November 04, 2010

Application No.Application TitleIssue Date
20100280256PROCESS FOR PREPARING TRIAZOLONES
The present process provides a improved method for the preparation of alkylsulfanyl substituted triazoles 2 which are useful intermediates in a new process for the preparation of triazolones 20.

...

11/04/2010
20100272677HETEROCYCLIC ANTIVIRAL COMPOUNDS
Compounds having the formula I wherein R1, R2, R3, R4, R5a, R5b, R5c and R6 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions an...
10/28/2010
20100160388DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS
Compounds of the formula I:

or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are m...

06/24/2010
20100160384DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS
Compounds of the formula I:

or pharmaceutically acceptable salts thereof, wherein m, n, p, q, R1, R2, R3, R4, R5 and R6 are as defined herein....

06/24/2010
20100160360JNK MODULATORS
Compounds of formula I modulate JNK:

wherein

    • X1
06/24/2010
20100144758AZAINDOLE P2X3 AND P2X2/3 MODULATORS
The application discloses compounds of the Formula I:

or a pharmaceutically acceptable salt thereof, wherein, X, R1, R2 R3, R4, R5, R6, R...

06/10/2010
20100068698PRODUCTION OF INFECTIOUS HEPATITIS C VIRUS PARTICLES IN CELL CULTURE
The present invention provides for novel methods of producing high levels of infectious HCV genotype 1 virus particles in cell culture systems. The availability of HCV genotype 1 virus (principally associated with liver disease in most regions of the world) that can und...
03/18/2010
20100063154POLYMORPHS OF ACYL SULFONAMIDES
The application discloses novel polymorphic crystalline forms of 2-[4-Bromo-3-(3-chloro-5-cyano-phenoxy)-2-fluoro-phenyl]-N-(2-chloro-4-propionylsulfamoyl-phenyl)-acetamide, sodium salt (Ib)

with improved sta...

03/11/2010
201000564993-AMINO-1-ARYLPROPYL AZAINDOLES AND USES THEREOF
The present invention provides compounds of the formula:

or pharmaceutically acceptable salts, solvates or prodrugs thereof,
wherein p, Ar, R1, R2, R3, Ra, R<...

03/04/2010
20100041648METHODS FOR TREATING RETROVIRAL INFECTIONS
The present invention provides compositions for treating an HIV infection comprising administering a compound according to formula I where Ar, R1-R5, R11c and X1 are as defined herein with at least one carrier, excipient or di...
02/18/2010
20090197934IMIDAZOLINYLMETHYL ARYL SULFONAMIDE
This invention relates to an alpha-1A receptor partial agonist, which is represented by Formula I:

and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical co...

08/06/2009
20090197933IMIDAZOLINYLMETHYL ARYL SULFONAMIDE
This invention relates to an alpha-1 A receptor partial agonist, which is represented by Formula I:

and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical c...

08/06/2009
20090197932IMIDAZOLINYLMETHYL ARYL SULFONAMIDE
This invention relates to an alpha-1A receptor partial agonist, which is represented by Formula I:

and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical co...

08/06/2009
20090197931IMIDAZOLINYLMETHY ARYL SULFONAMIDE
This invention relates to an alpha-1 A receptor partial agonist, which is represented by Formula I:

and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical c...

08/06/2009
20090170874Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists
Compounds of the formula I:

or a pharmaceutically acceptable salt thereof, wherein, R1 is optionally substituted triazolyl, and R2, R3, R4, R5, R6

07/02/2009
20090170873Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
Compounds of the formula I:

or a pharmaceutically acceptable salt thereof, wherein, R1 is optionally substituted pyrazolyl, and R2, R3, R4, R5, R6

07/02/2009
20090163499Imidazole-substituted arylamides as P2X3 and P2X2/3 antagonists
Compounds of the formula I:

wherein R1 is optionally substituted imidazolyl, and R2, R3, R4, R5, R6, R7 and R8 are as de...

06/25/2009
 
Sign InRegister
Username  
Password   
forgot password?